Tympanic Thermometer Study
Disco Thermometer Engineering Study Protocol
1 other identifier
observational
1,000
1 country
1
Brief Summary
The goal of this study is to collect febrile, healthy, and in some instances cold temperature data from human subjects ranging from newborns to geriatrics. This data will be used to develop a new thermometer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 11, 2022
CompletedFirst Submitted
Initial submission to the registry
August 12, 2024
CompletedFirst Posted
Study publicly available on registry
August 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedAugust 16, 2024
August 1, 2024
3.1 years
August 12, 2024
August 14, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical Bias
The mean difference between output temperatures of the clinical thermometer under test
Immediately after the diagnostic test
Secondary Outcomes (2)
Repeatability
Immediately after the diagnostic test
Limits of Agreement
Immediately after the diagnostic test
Study Arms (3)
Fever
Elevated oral temperature of 37.5C or higher or elevated axillary temperature of 37.2C or higher.
Healthy
Oral temperature between 36-37.4C Axillary temperature between 36-37.1C
Cold
Oral or axillary temperatures below 36C
Interventions
Collecting data on patients whose body temperatures increase due to fighting an illness.
Eligibility Criteria
Subjects recruited to participate in this study may range in age from normal weight (≥2.5kg), full-term (37 weeks gestation) newborns to geriatric adults. The subject may be anyone who is willing to have their temperature taken who also meets the eligibility criteria. Study subjects may have normal, febrile, or cold temperatures.
You may qualify if:
- Age: normal weight (≥2.5kg), full-term (37 weeks gestation) newborn to geriatric adult.
- Participant, legal guardian, or healthcare proxy is able to give consent to participate.
- Participant, legal guardian, or healthcare proxy speaks fluent English.
You may not qualify if:
- The subject has anatomical abnormalities that would affect temperature.
- The subject has blood or drainage in the external ear canal.
- The subject has had something in their ear for a prolonged period, such as a hearing aid or headphones. The subject may be included if the hearing aid or headphones are removed at least 30 minutes prior to taking ear temperature.
- The subject has been lying on ear within 30 minutes of data collection. The subject may be included if they wait 30 minutes prior to having an ear temperature measurement taken.
- The subject exhibits symptoms of an acute or chronic inflammatory condition of the external ear canal. An example would be swimmer's ear. The subject may be included if the acute or chronic inflammatory condition is isolated to one ear, then the other ear may be used for data collection.
- The subject has an ear obstruction or excess cerumen build-up.
- The subject is in acute distress, i.e., severe pain, severe emotional distress or agitation that would inhibit them from participating in a tympanic ear temperature study.
- The subject has any known contraindication to oral, ear, or axillary temperature measurements.
- The subject has used ear drops in the last 8 hours. The subject may be included if the other ear was not medicated with ear drops in the last 8 hours.
- The subject (age 5+) has consumed food or drink, or smoked, within the last 20 minutes. The subject may be included if they wait 20 minutes prior to taking oral temperature.
- The subject has taken an antipyretic (ex: Tylenol, Motrin, Aspirin) in the last 120 minutes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baxter
Skaneateles, New York, 13153, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2024
First Posted
August 16, 2024
Study Start
April 11, 2022
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
August 16, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share